-
Koren will take 1.9 billion anaesthetics for two firsts on the road
Time of Update: 2020-11-05
in the field of nervous systems, Colum Pharmaceuticals has two new classification products under review, and no first imitations have been approved.
-
Chengdu Yuandong Biofawei This anti-dementia drug first imitation will be taken down
Time of Update: 2020-11-05
In addition to the hydrochloric acid methion slow release capsule, Chengdu Yuandong Bio's Kapeta bin tablets, Glon ammonium bromide injection registration status has also been changed to "in the approval", the company will usher in a new intensive harvest period.
-
The chairman of North China Pharmaceuticals, a well-known pharmaceutical company, resigned
Time of Update: 2020-11-05
2020 semi-annual report, North China Pharmaceuticals achieved operating income of 5.621 billion yuan, up 5.42% YoY, and total profit of 142 million yuan, up 29.83% YoY.
-
Kun Chinese medicine airport brand image store opened
Time of Update: 2020-11-05
according to , Kun Traditional Chinese Medicine Airport brand image store is located in Kunming Changshui International Airport, the domestic departure level control area next to gate 17 (F3CA30), daily business hours of 6-22 o'clock, will show domestic and foreign passengers Kun Chinese medicine national non-relic culture and Kun medicine unique large health products.
-
Stone Pharmaceutical Group 2 heavy-weight varieties have been over-evaluated
Time of Update: 2020-11-05
Medicine Network October 29 - October 26, the Official Website of the State Drug Administration shows that Stone Pharmaceutical Group's Nofluosa star tablets, cephalospora capsules through a consistent evaluation.
-
The general manager of Tiansli, a well-known pharmaceutical company, resigned
Time of Update: 2020-11-04
On the appointment of the new general manager, Tian Shili said that Su Jing for many years in the marketing front line, understand the changing trends in the pharmaceutical industry, the future will focus on the market and patient needs, accelerate organizational efficiency, the implementation of customer demand-oriented business strategy.
-
East Sunshine drug impact 6 billion insulin varieties Sanofi 60% of the market is in a hurry.
Time of Update: 2020-10-28
Pharmaceutical network October 19 days ago, CDE official website shows that Yichang Dong Sunshine Changjiang Pharmaceuticals insulin insulin insulin injection application was accepted. 2019, sales of
-
Several pharmaceutical companies declared bankruptcy.
Time of Update: 2020-10-28
Under the influence of multiple policies based on volume procurement, the decline in profit margins of pharmaceutical commercial enterprises is obvious, and the large number of hospital drug use problems other than the national collection varieties are still unsolved, which has put a lot of pressure on the cash flow of pharmaceutical commercial enterprises.
-
Bei lu pharmaceutical industry to Yu Hengrui to grab the first imitation! The 15 billion-year-old imager market is back on the ups and downs.
Time of Update: 2020-10-28
meters intranet data show that in 2019 China's public medical institutions terminal imager sales of more than 15 billion yuan, in the product TOP20, the injection of niobol ranked 18th, the manufacturer of only Bayer.
-
Tagg a day to throw 900 million into the new medicine Kanglong into, Kailaiying a crowd of CXO pile into.
Time of Update: 2020-10-27
In recent years, the CXO industry has become a high-growth and stable gold industry, in the market competition pattern is stable, CXO companies holding a large amount of cash flow began to frequently through capital means, to participate in domestic pharmaceutical innovation ecology, in order to maximize the benefits.
-
Huahai has another class of new drugs to attack into the 10 billion eye market.
Time of Update: 2020-10-20
China's public medical institutions terminal ophthalmology drug sales (units: 100 million yuan) Source: Minet China's public medical institutions terminal competition pattern since this year, Huahai Pharmaceuticals has 3 new drugs approved clinical, respectively, recombinant human vascular endotkin growth factor subject - antibody fusion protein eye injection, HOT-1030 injection, HB0017 injection.
-
JD.com Health IPO: Gun to Ali Health.
Time of Update: 2020-10-19
promising prospects for the Internet healthcare industry have made players scrambling to enter the market more active, and JD.com's fourth carriage, JD.com Health, has also surfaced in this wave of surges.
-
CStone Pharmaceuticals Announces Successful Sale of US$200 Million Equity to Pfizer
Time of Update: 2020-10-19
equity subscription is part of the strategic cooperation framework between Cornerstone Pharmaceuticals and Pfizer, which will further transform Keystone Pharmaceuticals into a fully capable biopharmaceutical company by achieving its strategic, commercial and financial objectives.
-
Ten years of grinding a sword Li Zhu will take the first imitation of this heavy injection.
Time of Update: 2020-10-19
Medicine Network October 13 Source: The State Drug Administration's official website Danqulin sodium is a synactical muscle relaxant that can reduce skeletal muscle contractions and is clinically used
-
Lizhu, Qilu the same day into the 5 billion antifellarous large varieties Pfizer's arch-rivals will be.
Time of Update: 2020-10-17
Pharmaceutical network October 15th, October 14th, CDE official website data show that Lizhu, Qilu respectively declared the injection of Voliconazole 4 types of imitation listing applications, were accepted.
-
Well-known pharmaceutical companies filed for bankruptcy Many pharmaceutical companies have sold their assets.
Time of Update: 2020-10-17
recent announcement of Guoxin Health Disclosure also shows that in order to focus on the company's main business and further optimize the company's financial structure, the company intends to transfer 45% of Guangdong Haihong's shares through public listing.
-
To Yu Kanghong, Qilu Huahai stirred up 1 billion spiritual tantrums.
Time of Update: 2020-10-17
according to meters of intranet data, in recent years, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal sales of alecolytic tablets grew rapidly, in 2018 after breaking the 1 billion yuan mark, in 2019 to a new high, of which Chengdu Kanghong Pharmaceutical market share is the largest, accounting for nearly 50%.
-
Incorrigible? It's sunny and it's in the gold sales storm again.
Time of Update: 2020-10-10
senior industry insiders believe that "with gold sales" repeatedly banned, "positive day" have repeatedly taught, not only has a bad impact on the industry, exacerbated the tension between doctors and patients, but also exposed the drug registration excessive repetition of the malignant competition, and supervision, justice and other departments to work together to make rules, the urgent need to establish a accountability system.
-
China Resources announced the acquisition of well-known pharmaceutical company Boya Bio.
Time of Update: 2020-10-10
Pharma Network September 29 - The acquisition of Boya Bio by China Resources Pharmaceuticals is an important step in the field of blood products.
the acquisition of Boa Bio by China Resources Pharmaceuticals, or an important step in the field of blood products.
-
Well-known pharmaceutical company FangSheng Pharmaceuticals bought 6 large varieties.
Time of Update: 2020-10-03
The sales data of these varieties are as follows (some companies can not learn the relevant data from public sources): FangSheng Pharmaceuticals said in the announcement, the company to "drug listing license holder system" as an opportunity to actively reserve drug varieties with potential for development, enrich the company's product line, is conducive to promoting the integration of the industrial chain and industrial expansion, promote the company to become bigger and stronger quickly.
